Novo Nordisk A/S (NVO)
62.33
+5.21
(+9.12%)
USD |
NYSE |
Jan 16, 16:00
59.77
-2.56
(-4.11%)
Pre-Market: 06:48
Novo Nordisk EPS Diluted (Quarterly): 0.7044 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ascendis Pharma A/S | -1.173 |
| Evaxion AS | -0.2862 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Omeros Corp. | -0.4666 |
| Viking Therapeutics, Inc. | -0.8083 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.132B |
| Revenue (Quarterly) | 11.74B |
| Total Expenses (Quarterly) | 8.607B |
| Enterprise Value | 287.77B |
| Gross Profit Margin (Quarterly) | 76.12% |
| Profit Margin (Quarterly) | 26.68% |
| Earnings Yield | 5.51% |
| Operating Earnings Yield | 7.13% |
| Normalized Earnings Yield | 5.508 |